SUPN supernus.com: Korxona qiymatining sotish hajmiga nisbati

Supernus (SUPN) - korporativ logo

GURU.Markets kunlik grafigidagi Korxona qiymatining daromadga nisbati (Enterprise Value-to-Revenue) koeffitsienti nevrologik dori vositalariga barqaror talabni aks ettiradi va 2717.05 Supernus Pharmaceuticals (SUPN) uchun ushbu metrikaning joriy darajasini ko'rsatadi. O'sish ekologik toza dori ishlab chiqarish va ijtimoiy mas'uliyatga asoslangan. Biznesning defenziv xususiyatlari inqirozlarga chidamlilikni ta'minlaydi, chunki ADHD va epilepsiya terapiyasi YaIM dinamikasiga bog'liq emas.

Supernus Pharma - SUPN EV/Sales multiplikatori (davr: 23.11.2025 - 20.11.2026)

SUPN (Supernus Corp): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- pul mablag'lari va pul oqimlari ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:SUPN - Supernus Pharmaceuticals
Supernus Pharma tovar namunasi

EV/Sales koeffitsiyenti tendentsiyasi Supernus Pharmaceuticals (SUPN) kompaniyasining qarzlarini hisobga olgan holdagi bozor qiymatining yillik aylanmasiga nisbatini aks ettiradi va uning autsorsingga asoslangan ishlab chiqarish modelining samaradorligini ko'rsatadi. Ushbu koeffitsiyent umumiy korxona qiymatini tushumlar bilan solishtirib, investorlarga minimal kapital xarajatlar fonida R&D salohiyati uchun qo'shimcha qiymatni baholash imkonini beradi, bunda ko'rsatkichning keskin pasayishi dori vositalari marjining kamayishidan dalolat berishi mumkin.

Supernus Pharmaceuticals raqobatchilari tahlili

BIIB (Biogen Inc.) - Kompaniya qiymati va daromad nisbati|NBIX: EV/Sales multiplikatori|RGC (Regencell Bioscience Holdings Limited) - Korxona qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Axsome Therapeutics Inc|ACAD: Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori XENE|EV/Sales multiplikatori vikingtherapeutics.com (VKTX)|Korxona qiymatining daromadga nisbati Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Korxona qiymatining sotish hajmiga nisbati|Harmony Corp - EV/Sales multiplikatori|BHVN: Korxona qiymatining daromadga nisbati|AMLX: EV/Sales multiplikatori|TRVI: Korxona qiymati/daromad koeffitsiyenti|Korxona qiymatining daromadga nisbati Praxis Medicines|Korxona qiymati/daromad multiplikatori Anavex AVXL|Korxona qiymatining daromadga nisbati CeriBell Corp (CBLL)|Korxona qiymati/daromad koeffitsiyenti PRTA|EV/Sales multiplikatori ALEC (Alector)|Annexon (ANNX) - Korxona qiymati/daromad multiplikatori|OMER - Korxona qiymatining daromadga nisbati|NGNE (Neurogene) - Kompaniya qiymati va daromad nisbati|ACIU: EV/Sales multiplikatori|VYGR - Kompaniya umumiy qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Neumora Therapeutics, Inc.|Kompaniya qiymati va daromad nisbati SCLX (Scilex)|Kompaniya qiymatining daromadga nisbati TVGN (Tevogen Bio)|EV/Sales multiplikatori Alpha Cognition Inc (ACOG)|EV/Sales multiplikatori CGTX (cogrx.com)|Kompaniya umumiy qiymatining daromadga nisbati Inhibikase Pharma (IKT)|SAVA: Kompaniya qiymatining daromadga nisbati|Kompaniya umumiy qiymatining daromadga nisbati Assertio ASRT|COYA (coyatherapeutics.com) - Kompaniya qiymatining daromadga nisbati|Kompaniya qiymati va daromad nisbati VTGN|OVID (Ovid Therapeutics) - EV/Sales multiplikatori|Acumen Pharmaceuticals, Inc (ABOS) - Kompaniya umumiy qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati CervoMed, Inc. (CRVO)|ATHE - Korxona qiymati/daromad multiplikatori|EV/Sales multiplikatori CLNN (Clene Inc.)|Kompaniya umumiy qiymatining daromadga nisbati PepGen Inc. (PEPG)|JUNS - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Relmada Corp|ANVS (Annovis Bio, Inc.) - Kompaniya qiymatining daromadga nisbati|Grace Tx (GRCE) - EV/Sales multiplikatori|Kompaniya qiymatining daromadga nisbati AIFF|EV/Sales multiplikatori anewmeds.com|Korxona qiymatining daromadga nisbati NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Biznes qiymatining daromadga nisbati|MetaVia - Kompaniya qiymatining daromadga nisbati|NRXS: Kompaniya qiymati va daromad nisbati|Helius Medical Technologies, Inc. - EV/Sales multiplikatori|PASG: Korxona qiymatining daromadga nisbati|Neuphoria (NEUP) - Korxona qiymatining daromadga nisbati|Minerva Neurosciences - Biznes qiymatining daromadga nisbati|ATHA (Athira Pharma, Inc.) - EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori addextherapeutics.com ADXN|Kompaniya qiymatining daromadga nisbati ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori PTIX (Protagenic)|EV/Sales multiplikatori pasitheaclinics.com KTTA|CRGT - Korxona qiymatining daromadga nisbati|Biznes qiymatining daromadga nisbati ATXI (Avenue Therapeutics)|BCLI: EV/Sales multiplikatori|Cara Therapeutics - Biznes qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Chromocell Therapeutics Corporation|EV/Sales multiplikatori Eliem Therapeutics Inc.|Korxona qiymatining daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori MRNS (marinuspharma.com)|NKGN: Kompaniya qiymati va daromad nisbati|NRBO - Korxona qiymatining daromadga nisbati|SAGE - EV/Sales multiplikatori|Synaptogenix (SNPX) - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Trevena (TRVN)|Kompaniya qiymatining daromadga nisbati VIGL|Kompaniya qiymati va daromad nisbati WENA (Anew Medical)|EV/Sales multiplikatori CERE